Paul Huang

31PUBLICATIONS
111CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modellingForensic epidemiologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 09, 2025
Exploiting collateral sensitivity in the evolution of resistance to tyrosine kinase inhibitors in soft tissue sarcomas.

Mark L Elms, Andrew D Jenks, Avirup Chowdhury

|May 27, 2025
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS).

Dario Callegaro, Gabriele Tinè, Felix Boakye Oppong

|Jan 11, 2025
Novel Therapeutics in Soft Tissue Sarcoma.

Leonidas Mavroeidis, Andrea Napolitano, Paul Huang

|Sep 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.

Silvia Stacchiotti, Silvia Martini, Sandro Pasquali

|Aug 01, 2024
First-Line Tyrosine Kinase Inhibitors in Soft-Tissue Sarcomas: A Role for Anlotinib?

Andrea Napolitano, Paul H Huang, Robin L Jones

Pageof 6